These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1574121)

  • 1. Coley's toxins in perspective.
    Starnes CO
    Nature; 1992 May; 357(6373):11-2. PubMed ID: 1574121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective.
    Wiemann B; Starnes CO
    Pharmacol Ther; 1994; 64(3):529-64. PubMed ID: 7724661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coley's toxin: historical perspective.
    Bickels J; Kollender Y; Merinsky O; Meller I
    Isr Med Assoc J; 2002 Jun; 4(6):471-2. PubMed ID: 12073431
    [No Abstract]   [Full Text] [Related]  

  • 4. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas.
    McCarthy EF
    Iowa Orthop J; 2006; 26():154-8. PubMed ID: 16789469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriology: a caring culture.
    DeWeerdt S
    Nature; 2013 Dec; 504(7480):S4-5. PubMed ID: 24352362
    [No Abstract]   [Full Text] [Related]  

  • 6. A. Chekhov, M.D., and Coley's toxins.
    Gresser I
    N Engl J Med; 1987 Aug; 317(7):457. PubMed ID: 3302707
    [No Abstract]   [Full Text] [Related]  

  • 7. Fever and cancer in perspective.
    Hobohm U
    Cancer Immunol Immunother; 2001 Oct; 50(8):391-6. PubMed ID: 11726133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous regression: a hidden treasure buried in time.
    Hoption Cann SA; van Netten JP; van Netten C; Glover DW
    Med Hypotheses; 2002 Feb; 58(2):115-9. PubMed ID: 11812185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited.
    Decker WK; Safdar A
    Cytokine Growth Factor Rev; 2009 Aug; 20(4):271-81. PubMed ID: 19656718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The success of TNF alpha in isolated limb perfusion for irresectable extremity soft tissue sarcomas, melanoma and carcinomas: observations in patients and preclinical perfusion models.
    Eggermont AM
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1357-70. PubMed ID: 8854755
    [No Abstract]   [Full Text] [Related]  

  • 11. Historical note on bone and soft tissue sarcoma.
    Peltier LF
    J Surg Oncol; 1985 Dec; 30(4):201-5. PubMed ID: 3908827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of isolation-perfusion of the limbs in melanomas and sarcomas].
    Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Kroon B
    Ann Chir; 1995; 49(1):9-12. PubMed ID: 7741477
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma.
    Jakob J; von Rege I; Weiss C; Hohenberger P
    Int J Hyperthermia; 2012; 28(7):591-6. PubMed ID: 22946472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumours and Coley's toxins.
    Rook G
    Nature; 1992 Jun; 357(6379):545. PubMed ID: 1608465
    [No Abstract]   [Full Text] [Related]  

  • 15. Coley's vaccine and TNF therapy.
    Brouckaert PG; Fiers W; Lejeune FJ
    Nature; 1992 Aug; 358(6388):630. PubMed ID: 1495559
    [No Abstract]   [Full Text] [Related]  

  • 16. The Jeremiah Metzger Lecture: Of gold and pneumococci: a history of pneumococcal vaccines in South Africa.
    Austrian R
    Trans Am Clin Climatol Assoc; 1978; 89():141-61. PubMed ID: 30204
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience.
    Rastrelli M; Campana LG; Valpione S; Tropea S; Zanon A; Rossi CR
    Int J Hyperthermia; 2016; 32(2):165-72. PubMed ID: 26608883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
    Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
    Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased shedding of soluble TNF-receptor 1 during hyperthermic TNF-α-based isolated limb perfusion.
    Grabellus F; Podleska LE; Bjerlestam S; Sheu SY; Lendemans S; Schmid KW; Taeger G
    Int J Hyperthermia; 2011; 27(1):33-41. PubMed ID: 21073296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer.
    van Ginkel RJ; Kole AC; Nieweg OE; Molenaar WM; Pruim J; Koops HS; Vaalburg W; Hoekstra HJ
    J Nucl Med; 1999 Feb; 40(2):262-7. PubMed ID: 10025833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.